Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells

2013 ◽  
Vol 93 (3) ◽  
pp. 249-252 ◽  
Author(s):  
Maurizio Rossini ◽  
Silvano Adami ◽  
Ombretta Viapiana ◽  
Gaia Tripi ◽  
Roberta Zanotti ◽  
...  
1998 ◽  
Vol 7 (2) ◽  
pp. 128-131 ◽  
Author(s):  
Wayne M. Clark ◽  
Nancy B. Beamer ◽  
Michael Wynn ◽  
Bruce M. Coull

2011 ◽  
Vol 66 (2) ◽  
pp. 97-99 ◽  
Author(s):  
I. R. Reid ◽  
G. D. Gamble ◽  
P. Mesenbrink ◽  
P. Lakatos ◽  
D. M. Black

2017 ◽  
Vol 41 (3) ◽  
pp. 562-570 ◽  
Author(s):  
Emilie Glavind ◽  
Hendrik Vilstrup ◽  
Henning Grønbaek ◽  
Stephen Hamilton-Dutoit ◽  
Nils Erik Magnusson ◽  
...  

2013 ◽  
Author(s):  
Svetlana Yureneva ◽  
Oksana Yakushevskaya ◽  
Vera Smetnik ◽  
Gennady Sukchich

2008 ◽  
Vol 11 (4) ◽  
pp. 793-799 ◽  
Author(s):  
Tim Hofer ◽  
Luigi Fontana ◽  
Stephen D. Anton ◽  
Edward P. Weiss ◽  
Dennis Villareal ◽  
...  

1989 ◽  
Vol 257 (1) ◽  
pp. R189-R193
Author(s):  
L. W. Martin ◽  
L. B. Deeter ◽  
J. M. Lipton

Aspects of host defense, collectively called the acute phase response (APR), can be induced by central actions of cytokines. To determine whether aging alters this response, aged and young rabbits were given endogenous pyrogen (EP), a crude preparation containing interleukin 1 and other cytokines, via an intracerebroventricular cannula. Arterial blood was sampled before EP administration and 2, 4, and 24 h later. Measurements were made of changes in body temperature, white blood cells, neutrophils, concentration of antipyretic, anti-inflammatory peptide alpha-melanocyte stimulating hormone (alpha-MSH), corticosterone, and C-reactive protein (CRP) concentrations. EP caused greater fever and increases in corticosterone and CRP in young rabbits. EP-induced changes in circulating neutrophils did not show age-related differences. There was no significant change in alpha-MSH in either age group; thus only certain aspects of APR induced by central actions of EP were altered with aging. To determine whether changes in APR caused by peripherally administered cytokines are similar to those after central injection, young female rabbits were given EP by both routes. Although administration caused greater fever, increases in alpha-MSH and corticosterone concentrations and in neutrophil counts were greater after intravenous administration, perhaps the result of a combined influence on peripheral and central receptors. The EP-induced increase in circulating alpha-MSH is a new finding that indicates that this antipyretic and anti-inflammatory peptide is rapidly available to modulate host responses after challenge.


2014 ◽  
Vol 43 (6) ◽  
pp. 544-555 ◽  
Author(s):  
Georgia Kassi ◽  
Konstantinos Papamichael ◽  
Garyfallia Papaioannou ◽  
Irene Giagourta ◽  
Stavroula Thanou ◽  
...  

2010 ◽  
Vol 95 (9) ◽  
pp. 4380-4387 ◽  
Author(s):  
I. R. Reid ◽  
G. D. Gamble ◽  
P. Mesenbrink ◽  
P. Lakatos ◽  
D. M. Black

Context: Intravenous aminobisphosphonates often cause an acute-phase response (APR), but the precise components of this, its frequency, and the risk factors for its development have not been systematically studied. Objective: The objective of the study was to characterize the APR and determine its frequency and the risk factors for its development. Design: The study was an analysis of adverse events from a large randomized trial. Setting: This was a multicenter international trial. Patients: Patients included 7765 postmenopausal women with osteoporosis. Intervention: Zoledronic acid 5 mg annually or placebo was the intervention. Main Outcome Measure: Adverse events occurring within 3 d of zoledronic acid infusion were measured. Results: More than 30 adverse events were significantly more common in the zoledronic acid group and were regarded collectively as constituting an APR. These were clustered into five groups: fever; musculoskeletal (pain and joint swelling); gastrointestinal (abdominal pain, vomiting, diarrhea); eye inflammation; and general (including fatigue, nasopharyngitis, edema). A total of 42.4% of the zoledronic acid group had an APR after the first infusion, compared with 11.7% of the placebo group. All APR components had their peak onset within 1 d, the median duration of the APR was 3 d, and severity was rated as mild or moderate in 90%. Stepwise regression showed that APR was more common in non-Japanese Asians, younger subjects, and nonsteroidal antiinflammatory drug users and was less common in smokers, patients with diabetes, previous users of oral bisphosphonates, and Latin Americans (P < 0.05 for all). Conclusion: This analysis identifies new components of the APR and provides the first assessment of risk factors for it. Despite its frequency, APR rarely resulted in treatment discontinuation in this study.


Sign in / Sign up

Export Citation Format

Share Document